Duke University Medical Center, Durham, NC.
Duke Clinical Research Institute, Durham, NC.
Med Sci Sports Exerc. 2018 Jul;50(7):1345-1349. doi: 10.1249/MSS.0000000000001587.
The prognostic value of peak V˙O2 and V˙E/V˙CO2 slope measured during cardiopulmonary exercise (CPX) testing has been well established in patients with advanced heart failure, but blood pressure response to exercise is less well characterized.
We retrospectively studied 151 outpatients who underwent CPX testing as part of an advanced heart failure evaluation. The outcome of interest was failure of medical management, defined by death, cardiac transplantation, or left ventricular assist device placement. Patients were stratified into tertiles by change in systolic blood pressure (SBP) (<13, 13-26, and ≥27 mm Hg) during exercise.
Patients in the lowest tertile had the lowest peak V˙O2 (10.2 vs 10.6 vs 13.6 mL·kg·min, P = <0.001), the highest V˙E/V˙CO2 slope (42.8 vs 42.1 vs 36.3, P = 0.030), the shortest mean exercise time (5.1 vs 6.0 vs 7.0 min, P = <0.001), and the highest probability of failure of medical management at 1.5 yr (0.69 vs 0.41 vs 0.34, P = 0.011). After multivariate adjustment, increased SBP <20 mm Hg during exercise was associated with a lower hazard of medical management failure (hazard ratio = 0.96, 95% confidence interval [CI] = 0.934-0.987), whereas SBP increases >20 mm Hg were associated with an increased hazard (hazard ratio = 1.046, 95% CI = 1.018-1.075).
In conclusion, changes in SBP during CPX testing provide additional prognostic information above standard clinical variables. The peculiar increase in risk noted in those with a rise in SBP >20 mm Hg is less clear and needs to be investigated further.
在晚期心力衰竭患者中,心肺运动(CPX)测试中测量的峰值 V˙O2 和 V˙E/V˙CO2 斜率的预后价值已经得到充分证实,但血压对运动的反应尚不清楚。
我们回顾性研究了 151 名接受 CPX 测试的门诊患者,这些患者是晚期心力衰竭评估的一部分。感兴趣的结局是药物治疗失败,定义为死亡、心脏移植或左心室辅助装置植入。根据运动期间收缩压(SBP)的变化(<13、13-26 和≥27mmHg),患者被分为三分位。
最低三分位的患者峰值 V˙O2 最低(10.2 比 10.6 比 13.6mL·kg·min,P<0.001),V˙E/V˙CO2 斜率最高(42.8 比 42.1 比 36.3,P=0.030),平均运动时间最短(5.1 比 6.0 比 7.0 分钟,P<0.001),1.5 年时药物治疗失败的概率最高(0.69 比 0.41 比 0.34,P=0.011)。在多变量调整后,运动时 SBP 增加<20mmHg 与药物治疗失败的风险降低相关(危险比=0.96,95%置信区间[CI]:0.934-0.987),而 SBP 增加>20mmHg 与风险增加相关(危险比=1.046,95%CI:1.018-1.075)。
总之,CPX 测试中 SBP 的变化提供了标准临床变量之外的额外预后信息。对于 SBP 升高>20mmHg 的患者,风险增加的特殊情况不太清楚,需要进一步研究。